Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
McKinsey
Merck
AstraZeneca
Argus Health
Dow
UBS
Mallinckrodt
US Army
Teva

Generated: August 19, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Method for treatment or prophylaxis of cardiac disorders
Abstract:A method for the treatment or prophylaxis of cardiac disorders in a mammal, comprising administering to such mammal a short-acting .beta.-blocking compound of the formula: ##STR1## wherein R may be lower alkyl, aryl, or aralkyl; n may be an integer from 0 to about 10; x may be an integer from 1 to 3; Ar may be substituted or unsubstituted aromatic; R.sub.1 may be lower alkyl, or aralkyl; and pharmaceutically accepted salts thereof. Novel compounds possessing short-acting .beta.-adrenergic blocking activity are also disclosed.
Inventor(s): Erhardt; Paul W. (Mundelein, IL), Borgman; Robert J. (Mundelein, IL), O'Donnell; John P. (Morgantown, WV)
Assignee: American Hospital Supply Corporation (Evanston, IL)
Application Number:06/450,228
Patent Claims: 1. A compound of the formula ##STR23## wherein R is methyl or ethyl; the ester-containing group is in the para position on the phenyl ring with respect to the amine-containing group; n is 2; R.sub.1 is lower alkyl of from 1 to about 5 carbon atoms; and Y is hydrogen, lower alkyl of from 1 to about 5 carbon atoms, lower alkenyl of from 2 to about 5 carbon atoms, lower alkynyl of from 2 to about 5 carbon atoms, lower alkoxy of from 1 to about 5 carbon atoms, halogen, acetamido, amino, nitro, lower alkylamino of from 1 to about 5 carbon atoms, hydroxy, lower hydroxyalkyl of from 1 to about 5 carbon atoms, or cyano; or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1, wherein Y is lower alkyl of form 1 to about 5 carbon atoms, fluoro or chlor.

3. The compound of claim 1, or 2, wherein R is methyl or ethyl, and R.sub.1 is isopropyl or t-butyl.

4. The compund of claim 3, wherein R.sub.1 is isopropyl.

5. The compound of claim 1, of the formula ##STR24## or its pharmaceutically acceptable salt.

6. The compound of claim 1, of the formula ##STR25## or its pharmaceutically acceptable salt.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
UBS
Moodys
Express Scripts
Mallinckrodt
QuintilesIMS
Cerilliant
Farmers Insurance
Johnson and Johnson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot